Collaboration the only viable way to protect the pharma supply chain, warns GSK

14/12/2015

Pharmaceutical manufacturers and their supply chain partners need to improve their business continuity planning to deal with threats from terrorist attacks, political instability and unforeseen climate events, according to Stephen Mitchell, quality assurance and compliance manager at GlaxoSmithKline.

Dr Mitchell warned the Air Cargo News Life ...

To read this article you need to subscribe.

Help us to continue to invest in award-winning independent journalism. For an introductory offer of just £70 a year, or £10 per month, get access to all our daily news stories and opinion. If you are already a registered user, please login below with your current account's email and password to subscribe. If you are not registered and want to subscribe, please register below to subscribe.

Current subscriber

New subscriber